1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborlan-2-yl-)-1H-pyrazole, 98.0%, 1g

tert-Butyl ((3S,5R)-5-fluoropiperidin-3-yl)carbamate, 95.0%, 250mg

1,4-Dichlorbenzol, >=99 %, zur Synthese, 2.5 kg, kunststoffverpackung.

Methyl (R)-2-(morpholin-3-yl)acetate hydrochloride, 95+%, 250mg

N-Cyclopropyl-1-(3-fluorophenyl)methanesulfonamide, 95.0%, 100mg

(S)-3,3'-BIS(4-(TRIFLUOROMETHYL)PHENYL)-5,5',6,6',7,7',8,8'-OCTAHYDRO-[1,1'-BINAPHTHALENE]-2,2'-DIOL, 95%, 250mg

[1,2,4]Triazolo[1,5-a]pyridine-8-carbaldehyde, 95%, 250mg

Ethyl 4-bromo-1H-indole-2-carboxylate, 95.0%, 1g

(S)-(-)-1,1'-Binaphthyl-2,2'-diamine, 95.0%, 25g

6-Bromoimidazo[1,2-a]pyrimidine, 95.0%, 1g

5-AMINO-2-BROMO-ISONICOTINIC ACID METHYL ESTER, 95.0%, 25g

8-Bromo-2,4-dichloroquinoline, 95.0%, 5g

1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22-hexaoxa-4-azapentacosan-25-oic acid, 95%, 250mg